Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Up Cannabis is a Canadian licensed producer of medical and recreational cannabis, originally operating as the primary brand of Newstrike Brands Ltd. The company is recognized for its high-quality, indoor-grown cannabis products and its unique branding partnership with the iconic Canadian rock band, The Tragically Hip. Following its acquisition by HEXO Corp in 2019, and the subsequent acquisition of HEXO by Tilray Brands in 2023, Up Cannabis continues to offer a range of dried flower, oils, and pre-rolled products. Its operations focus on providing consistent cannabinoid profiles to address various consumer needs and therapeutic applications. The brand emphasizes a 'craft' approach to large-scale cultivation, utilizing advanced indoor facilities in Ontario.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Up Cannabis.